Tamoxifen Treatment and New – Onset Depression in Breast Cancer Patients
Lee K.C., et al. – The authors conducted a retrospective cohort study of female patients diagnosed with breast cancer (BRCA), evaluating the risk of new-onset depression associated with tamoxifen treatment among those with estrogen receptor-positive (ER+) tumors, versus estrogen receptor-negative
3 min read